![]() |
|
|
Vol. 285, Issue 2, 835-843, May 1998
Departments of
Medicine (S.A.M., T.R.K., X-Y.C.),
Psychiatry
(S.A.M.) and
Physiology (T.R.K.), University of Pennsylvania School of
Medicine, Philadelphia VAMC, Philadelphia, Pennsylvania
Long-term exposure to cocaine can cause persistent behavioral changes
and alterations in neuronal function. One cocaine-regulated mRNA in
the rat brain is the beta-1 subunit of the
Na+/K+-ATPase pump. We examined both
Na+/K+-ATPase function and expression after
cocaine treatment of pheochromocytoma cells. One-hour exposure to
cocaine did not alter Na+/K+-ATPase activity,
as measured by the ouabain-sensitive component of rubidium uptake. Four
days of cocaine resulted in an ~30% decrease in
Na+/K+-ATPase activity. Western blot analyses
demonstrated an ~25% decrease in levels of the beta-1
isoform, without changes in pump total alpha subunit
levels. Treatment with dopamine type 1 or type 2 receptor agonists for
the same period did not affect Na+/K+-ATPase
activity. The serotonin-selective reuptake inhibitor paroxetine caused
an ~45% decrease in rubidium uptake after 4 days, whereas pump
function was not altered after treatment with either the dopamine-selective reuptake blocker nomifensine or the
norepinephrine-selective reuptake blocker desipramine. Chronic
treatment with both cocaine and LY 278,584, a serotonin type 3 receptor
antagonist, did not replicate the cocaine-associated decrease in pump
function. Long-term cocaine exposure regulates expression and function
of the Na+/K+-ATPase pump in neuronal-like
cells; this regulation is mediated in part via the
serotonin type 3 receptor. Similar
Na+/K+-ATPase pump regulation in
vivo may selectively alter neuronal function in the mammalian
brain.